STOCK TITAN

Lesaka Technologies (NASDAQ: LSAK) pushes Bank Zero deal deadline to January 31, 2027

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Lesaka Technologies, Inc. reports an amendment to the timetable for a previously announced acquisition. Its subsidiary, Lesaka Technologies Proprietary Limited, had signed a Transaction Implementation Agreement to acquire interests in Bank Zero Mutual Bank and related entities. The parties have now agreed to extend the deadline to fulfill or waive remaining conditions precedent from August 6, 2026 to January 31, 2027 while outstanding regulatory consents are obtained.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Original long-stop date August 6, 2026 Deadline for fulfilling or waiving conditions precedent
Extended long-stop date January 31, 2027 New deadline agreed on June 11, 2026
Agreement announcement date June 26, 2025 Date Lesaka announced the Transaction Implementation Agreement
Extension agreement date June 11, 2026 Date Lesaka SA and sellers’ representative agreed to extend
Transaction Implementation Agreement financial
"Lesaka Technologies Proprietary Limited had entered into a Transaction Implementation Agreement with Zero Research Proprietary Limited"
conditions precedent financial
"The Transaction Implementation Agreement will lapse if the outstanding conditions precedent are not fulfilled or waived"
Conditions precedent are the specific tasks, approvals, or facts that must be satisfied before a contract or transaction becomes effective or a payment is made. Think of them as a checklist you must complete before turning the key on a new machine; if items are missing the deal can be delayed, renegotiated, or canceled. Investors watch these conditions because they determine timing, completion risk, and whether expected benefits will actually occur.
regulatory consents regulatory
"date from August 6, 2026, to January 31, 2027, while the remaining outstanding regulatory consents are being procured"
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Inline XBRL technical
"Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

false 2026-06-11 0001041514 Lesaka Technologies, Inc. 0001041514 2026-06-11 2026-06-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 11, 2026

LESAKA TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Florida 000-31203 98-0171860
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

President Place, 4th Floor, Cnr.
Jan Smuts Avenue and Bolton Road
Rosebank, Johannesburg, South Africa
(Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: + 27-11-343-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Shares   LSAK   NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 1.01 Entry Into a Material Definitive Agreement.

Transaction Implementation Agreement

On June 26, 2025, Lesaka Technologies, Inc. ("Lesaka") announced that its wholly owned subsidiary, Lesaka Technologies Proprietary Limited ("Lesaka SA"), had entered into a Transaction Implementation Agreement (the "Transaction Implementation Agreement") with Zero Research Proprietary Limited ("Zero Research"), Bank Zero Mutual Bank ("Bank Zero"), the parties identified in Annexure A to the Transaction Implementation Agreement (being all of the shareholders of Bank Zero save for Zero Research and Naught Holdings Ltd), the parties listed in Annexure B to the Transaction Implementation Agreement (being all of the shareholders of Zero Research save for Naught Holdings Ltd) and Naught Holdings Ltd.

The Transaction Implementation Agreement will lapse if  the outstanding conditions precedent are not fulfilled or, if permitted, waived by August 6, 2026 (or such later date as may be agreed between Lesaka SA and the Sellers' representative).  On June 11, 2026, Lesaka SA and the Sellers' representative agreed to extend this date from August 6, 2026, to January 31, 2027, while the remaining outstanding regulatory consents are being procured.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibits Description
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  LESAKA TECHNOLOGIES, INC.
     
Date: June 17, 2026 By: /s/ Dan Smith
  Name: Dan Smith
  Title: Group Chief Financial Officer


FAQ

What did Lesaka Technologies (LSAK) disclose in this 8-K filing?

Lesaka disclosed that its subsidiary and the sellers’ representative amended their Transaction Implementation Agreement by extending the deadline to satisfy remaining conditions precedent, mainly regulatory consents, from August 6, 2026, to January 31, 2027. The underlying transaction terms were not changed in this update.

Which transaction is affected by Lesaka Technologies’ (LSAK) deadline extension?

The extension applies to the Transaction Implementation Agreement involving Lesaka’s subsidiary, Zero Research Proprietary Limited, Bank Zero Mutual Bank, various shareholders listed in annexures, and Naught Holdings Ltd. The agreement governs Lesaka’s planned acquisition structure related to Bank Zero and associated shareholders.

How was the Transaction Implementation Agreement deadline for Lesaka (LSAK) changed?

The long-stop date for fulfilling or, where allowed, waiving conditions precedent was originally August 6, 2026. On June 11, 2026, Lesaka’s subsidiary and the sellers’ representative agreed to move this date to January 31, 2027 to allow time for remaining regulatory consents.

Why did Lesaka Technologies (LSAK) extend the Transaction Implementation Agreement date?

The date was extended because certain regulatory consents required under the Transaction Implementation Agreement have not yet been obtained. The parties agreed to shift the deadline to January 31, 2027 so they can continue working to secure these outstanding regulatory approvals and satisfy conditions precedent.

Does the Lesaka (LSAK) filing describe any new financial terms for the Bank Zero deal?

The filing focuses only on extending the deadline for conditions precedent and mentions that regulatory consents are still being procured. It does not describe or change any financial terms of the Transaction Implementation Agreement in the provided excerpt, keeping the disclosure administrative in nature.

Filing Exhibits & Attachments

5 documents